Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...

Dapagliflozin propanediol is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used to treat type 2 diabetes, heart failure, and chronic kidney disease. By reducing glucose reabsorption in the ...

The biggest advantage of the drug going off patent is that the prices will plummet. The patented medicine, sold as Jardiance, ...

Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes ...

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.

The study showed that treatment with Farxiga (dapagliflozin) led to an 18% reduction in cardiovascular death or worsening heart failure in patients with both mildly reduced and preserved ejection ...

For this study, researchers focused on the SGLT-2 drug dapagliflozin, and how it worked in combination with a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit ...

AZ’s ZENITH-CKD study looked at the combination of its SGLT2 drug dapagliflozin with zibotentan, an endothelin A (ETA) receptor antagonist, on levels of albumin in the urine (albuminuria), a ...

Kolkata: The prices of 53 medicines, including a large number of formulations used to treat diabetes, have been revised ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...